Evidence map›Paper›PMID 37906238›Full record

ArticleThe Canadian journal of cardiology2024

The Canadian Cardiovascular Society Classification of Acute Atherothrombotic Myocardial Infarction Based on Stages of Tissue Injury Severity: An Expert Consensus Statement.

Andreas Kumar, Kim Connelly, Keyur Vora, Kevin R Bainey, Andrew Howarth, Jonathon Leipsic, Suzanne Betteridge-LeBlanc, Frank S Prato, Howard Leong-Poi, Anthony Main and 6 more

Registry-linked trialOpen access · bronzeAbstract readConsensus Statement
In one paragraph

Article in The Canadian journal of cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07163988 (High-Sensitivity Cardiac Troponin I as a Diagnostic Marker for AMI Clinical Stage Classification in Acute Myocardial Infarction), which is not on this map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07163988 completednot on this map

High-Sensitivity Cardiac Troponin I as a Diagnostic Marker for AMI Clinical Stage Classification in Acute Myocardial Infarction: A Retrospective Multicenter Study

Typeobservational_patient_registrySponsorRohan DharmakumarRan2023 to 2025Enrolled312ConditionsAcute Myocardial Infarction (AMI)
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 34 citations in OpenAlex.

  1. Magneto-responsive piezoelectric CoFeMaterials today. Bio · 2026
    Article
  2. Article
  3. Cardiac MRI as Living Histology: Tissue-Based Risk Stratification After STEMI.Journal of magnetic resonance imaging : JMRI · 2026
    Article
  4. Evidence for Electrocardiographic Patterns Identifying Acute Coronary Occlusion in Non-ST-Elevation Acute Coronary Syndromes: A Scoping Review.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

Andreas KumarNorthern Ontario School of Medicine University, and Department of Cardiovascular Sciences, Health Sciences North, Sudbury, Ontario, Canada; Health Sciences North, Sudbury, Ontario, Canada. Electronic address: Andreas.kumar@mac.com.
Kim ConnellyKeenan Research Centre for Biomedical Science, Unity Health Toronto, St Michael's Hospital, University of Toronto, and Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
Keyur VoraKrannert Cardiovascular Research Center, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Kevin R BaineyUniversity of Alberta, Faculty of Medicine and Dentistry, Mazankowski Alberta Heart Institute, Canadian VIGOUR Centre, Edmonton, Alberta, Canada.
Andrew HowarthCardiac Sciences, Faculty of Medicine, University of Calgary, and Libin Cardiovascular Institute, Calgary, Alberta, Canada.
Jonathon LeipsicDepartments of Radiology and Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
Suzanne Betteridge-LeBlancHealth Sciences North, Sudbury, Ontario, Canada; Northern Ontario School of Medicine University, and Health Sciences North, Sudbury, Ontario, Canada.
Frank S PratoLawson Research Institute, University of Western Ontario, London, Ontario, Canada.
Howard Leong-PoiThe Division of Cardiology, St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada.
Anthony MainNorthern Ontario School of Medicine University, and Department of Cardiovascular Sciences, Health Sciences North, Sudbury, Ontario, Canada; Health Sciences North, Sudbury, Ontario, Canada.
Rony AtouiNorthern Ontario School of Medicine University, and Department of Surgery, Health Sciences North, Sudbury, Ontario, Canada.
Jacqueline SawDivision of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Eric LaroseDepartment of Medicine, University of Laval, Quebec City, Quebec, Canada.
Michelle M GrahamDivision of Cardiology, University of Alberta, Faculty of Medicine and Dentistry, Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.
Marc RuelUniversity of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Rohan DharmakumarKrannert Cardiovascular Research Center, Indiana University School of Medicine/IU Health Cardiovascular Institute, Indianapolis, Indiana, USA.
Health Sciences North · CASt. Michael's Hospital · CAUniversity of Alberta · CAUniversity of British Columbia · CAIndiana University Health · USIndiana University School of MedicineUniversité Laval · CAUniversity of Calgary · CAUniversity of Ottawa · CAWestern University · CA

Funding

Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart FailureR01HL133407 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI Rohan Dharmakumar · 2017 to 2026
$4.9M
An Accurate Non-Contrast-Enhanced Cardiac MRI Method for Imaging Chronic Myocardial Infarctions: Technical Developments to Rapid Clinical ValidationR01HL136578 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI LI, DEBIAO · 2017 to 2020
$3.4M
Mechanistic Insights to A Translatable Therapy for Acute Reperfused Hemorrhagic Myocardial InfarctionsR01HL147133 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI DHARMAKUMAR, ROHAN, FRANCIS, JOSEPH · 2020 to 2023
$3.2M
NHLBI NIH HHS R01 HL133407NHLBI NIH HHS R01 HL136578NHLBI NIH HHS R01 HL147133
6 · The paper itself

Abstract

Myocardial infarction (MI) remains a leading cause of morbidity and mortality. In atherothrombotic MI (ST-elevation MI and type 1 non-ST-elevation MI), coronary artery occlusion leads to ischemia. Subsequent cardiomyocyte necrosis evolves over time as a wavefront within the territory at risk. The spectrum of ischemia and reperfusion injury is wide: it can be minimal in aborted MI or myocardial necrosis can be large and complicated by microvascular obstruction and reperfusion hemorrhage. Established risk scores and infarct classifications help with patient management but do not consider tissue injury characteristics. This document outlines the Canadian Cardiovascular Society classification of acute MI. It is an expert consensus formed on the basis of decades of data on atherothrombotic MI with reperfusion therapy. Four stages of progressively worsening myocardial tissue injury are identified: (1) aborted MI (no/minimal myocardial necrosis); (2) MI with significant cardiomyocyte necrosis, but without microvascular injury; (3) cardiomyocyte necrosis and microvascular dysfunction leading to microvascular obstruction (ie, "no-reflow"); and (4) cardiomyocyte and microvascular necrosis leading to reperfusion hemorrhage. Each stage reflects progression of tissue pathology of myocardial ischemia and reperfusion injury from the previous stage. Clinical studies have shown worse remodeling and increase in adverse clinical outcomes with progressive injury. Notably, microvascular injury is of particular importance, with the most severe form (hemorrhagic MI) leading to infarct expansion and risk of mechanical complications. This classification has the potential to stratify risk in MI patients and lay the groundwork for development of new, injury stage-specific and tissue pathology-based therapies for MI.

Indexed as

Myocardial InfarctionReperfusion InjuryCanadaHemorrhageHumansNecrosis

Identifiers

PMID37906238
PMCPMC13016900
OpenAlexW4388005647

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.